Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complicated problems in testicular cancer.

L H Einhorn1

  • 1Department of Medicine, Indiana University Medical Center, Indianapolis.

Seminars in Oncology
|June 1, 1988
PubMed
Summary

Testicular cancer is now highly curable, with over 90% of patients cured. For early-stage nonseminomatous germ cell tumors, routine retroperitoneal lymph node dissection (RPLND) is advocated despite surveillance options.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Long-term toxicity of cisplatin in germ-cell tumor survivors.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Utilization of sperm banking and barriers to its use in testicular cancer patients.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2015

Area of Science:

  • Oncology
  • Urologic Oncology

Background:

  • Testicular cancer, though rare, is a model for curable neoplasms.
  • Cisplatin chemotherapy has dramatically improved cure rates, exceeding 90% overall and 80% for disseminated disease.

Purpose of the Study:

  • To discuss the evolving management of clinical stage I testicular cancer.
  • To advocate for routine retroperitoneal lymph node dissection (RPLND) in specific early-stage cases.

Main Methods:

  • Review of current treatment strategies for testicular cancer.
  • Discussion of the role of retroperitoneal lymph node dissection (RPLND) versus surveillance.
  • Evaluation of salvage chemotherapy and high-dose regimens.

Main Results:

  • Over 90% cure rate for testicular cancer patients.
  • 80% cure rate for disseminated testicular cancer.
  • Ongoing refinement of salvage chemotherapy and high-dose regimens.

Conclusions:

  • Routine RPLND is recommended for clinical stage I nonseminomatous germ cell tumors.
  • Advances allow focus on subsets of patients with advanced disease.
  • Future efforts aim to improve the therapeutic index in testicular cancer treatment.

Related Experiment Videos